Market Overview

UPDATE: Oppenheimer Raises PT to $37 on Oracle Following Positive Q2 Results

Related ORCL
Oracle Conference Call Highlights
Oracle Analyst Roundup After Q2 Earnings
Dovish Fed Continues to Fuel Street Rally (Fox Business)

Oppenheimer reiterated its Outperform rating on Oracle (NASDAQ: ORCL) and increased its price target from $36 to $37.

Oppenheimer said, "We believe Oracle's internally-driven new product-cycles are gaining traction within the base, and as the uptake becomes more meaningful (over the next 12-18 months) it should start yielding greater operating leverage and serve as a catalyst to drive a revaluation of the stock multiple."

Oracle closed at $32.88 on Tuesday.

Latest Ratings for ORCL

DateFirmActionFromTo
Dec 2014Credit SuisseMaintainsOutperform
Dec 2014BarclaysMaintainsOverweight
Dec 2014FBR CapitalMaintainsOutperform

View More Analyst Ratings for ORCL
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (ORCL)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional